Lytix Biopharma ASA (OSL:LYTIX)
Norway · Delayed Price · Currency is NOK 9.50
0.00 (0.00%)
Jun 24, 2026, 4:25 PM CET
Lytix Biopharma ASA Market Cap
Lytix Biopharma ASA has a market cap or net worth of 730.55 million as of June 24, 2026. Its market cap has increased by 24.44% in one year.
Market Cap
730.55M
Enterprise Value
660.39M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9.50
Market Cap Chart
Since June 14, 2021, Lytix Biopharma ASA's market cap has increased from 720.55M to 730.55M, an increase of 1.39%. That is a compound annual growth rate of 0.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 730.55M | 8.32% |
| Dec 30, 2025 | 674.43M | 68.03% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
| Jun 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 1.95B |
| Thor Medical ASA | 1.53B |
| Nykode Therapeutics AS | 1.06B |
| ArcticZymes Technologies ASA | 1.03B |
| Zelluna ASA | 555.92M |
| SoftOx Solutions AS | 281.10M |
| Oncoinvent ASA | 219.44M |
| Arctic Bioscience AS | 88.96M |